Oncolytic virus-initiated protective immunity against prostate cancer

Shashi A. Gujar; Da Pan; Paola Marcato; Katy A. Garant; Patrick W.K. Lee

doi:10.1038/mt.2010.297

Oncolytic virus-initiated protective immunity against prostate cancer

Shashi A. Gujar, Da Pan, Paola Marcato, Katy A. Garant, Patrick W.K. Lee

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	797-804
Number of pages	8
Journal	Molecular Therapy
Volume	19
Issue number	4
DOIs	https://doi.org/10.1038/mt.2010.297
Publication status	Published - Apr 2011

ASJC Scopus Subject Areas

Molecular Medicine
Molecular Biology
Genetics
Pharmacology
Drug Discovery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/mt.2010.297

Cite this

Gujar, S. A., Pan, D., Marcato, P., Garant, K. A., & Lee, P. W. K. (2011). Oncolytic virus-initiated protective immunity against prostate cancer. Molecular Therapy, 19(4), 797-804. https://doi.org/10.1038/mt.2010.297

@article{47d92a9a378242ba823319c28eb3ddc2,

title = "Oncolytic virus-initiated protective immunity against prostate cancer",

author = "Gujar, {Shashi A.} and Da Pan and Paola Marcato and Garant, {Katy A.} and Lee, {Patrick W.K.}",

note = "Funding Information: This work was supported by an operating grant from the Canadian Cancer Society Research Institute (CCSRI) through the Terry Fox Foundation, and Canadian Institutes for Health Research (CIHR) to P.W.K.L. S.A.G. and D.P. receive postdoctoral and doctoral fellowships, respectively, from the Cancer Research Training Program (CRTP).",

year = "2011",

month = apr,

doi = "10.1038/mt.2010.297",

language = "English",

volume = "19",

pages = "797--804",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Oncolytic virus-initiated protective immunity against prostate cancer

AU - Gujar, Shashi A.

AU - Pan, Da

AU - Marcato, Paola

AU - Garant, Katy A.

AU - Lee, Patrick W.K.

N1 - Funding Information: This work was supported by an operating grant from the Canadian Cancer Society Research Institute (CCSRI) through the Terry Fox Foundation, and Canadian Institutes for Health Research (CIHR) to P.W.K.L. S.A.G. and D.P. receive postdoctoral and doctoral fellowships, respectively, from the Cancer Research Training Program (CRTP).

PY - 2011/4

Y1 - 2011/4

UR - http://www.scopus.com/inward/record.url?scp=79953294511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953294511&partnerID=8YFLogxK

U2 - 10.1038/mt.2010.297

DO - 10.1038/mt.2010.297

M3 - Article

AN - SCOPUS:79953294511

SN - 1525-0016

VL - 19

SP - 797

EP - 804

JO - Molecular Therapy

JF - Molecular Therapy

IS - 4

ER -

Oncolytic virus-initiated protective immunity against prostate cancer

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this